|
|
???tair.name??? >
???browser.page.title.author???
|
"lee ty"???jsp.browse.items-by-author.description???
Showing items 11-20 of 91 (10 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page
| 中山醫學大學 |
2021 |
Establishing the blood reference interval of pancreatic elastase-1: A prospective study
|
Chi, SF; Lai, CY; Dong, WT; Wang, JM; Wang, YY; Yang, SS; Lin, JT; Lee, TY |
| 中山醫學大學 |
2021 |
The correlation with tumor radiological characteristics and prognosis of patients with early-stage hepatocellular carcinoma receiving transcatheter arterial chemoembolization
|
Lee, SW; Lee, TY; Cheng, YC; Yen, CL; Yang, SS |
| 中山醫學大學 |
2021 |
Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a multicentre, double-blind, placebo-controlled, parallel-group, randomised trial
|
Hsu, YC; Chen, CY; Chang, IW; Chang, CY; Wu, CY; Lee, TY; Wu, MS; Bair, MJ; Chen, JJ; Chen, CC; Tseng, CH; Tai, CM; Huang, YT; Ku, WH; Mo, LR; Lin, JT |
| 中山醫學大學 |
2021 |
Evaluating the renal safety of tenofovir disoproxil fumarate in hepatitis B patients without chronic kidney disease
|
Tsai, HJ; Chuang, YW; Yang, SS; Chang, YZ; Chang, HR; Lee, TY |
| 中山醫學大學 |
2021 |
Cessation of Nucleos(t)ide Analogue Therapy in Non-Cirrhotic Hepatitis B Patients with Prior Severe Acute Exacerbation
|
Lai, CY; Yang, SS; Lee, SW; Tsai, HJ; Lee, TY |
| 國家衛生研究院 |
2020-04-28 |
Association of daily Aspirin therapy with Hepatocellular Carcinoma risk in patients with chronic Hepatitis C Virus infection
|
Lee, TY;Hsu, YC;Tseng, HC;Lin, JT;Wu, MS;Wu, CY |
| 國家衛生研究院 |
2020-03-30 |
Atorvastatin-induced senescence of hepatocellular carcinoma is mediated by downregulation of hTERT through the suppression of the IL-6/STAT3 pathway
|
Wang, ST;Huang, SW;Liu, KT;Lee, TY;Shieh, JJ;Wu, CY |
| 國家衛生研究院 |
2020-03-30 |
Atorvastatin-induced senescence of hepatocellular carcinoma is mediated by downregulation of hTERT through the suppression of the IL-6/STAT3 pathway
|
Wang, ST;Huang, SW;Liu, KT;Lee, TY;Shieh, JJ;Wu, CY |
| 中山醫學大學 |
2020 |
The therapeutic benefits of combined sorafenib and transarterial chemoembolization for advanced hepatocellular carcinoma
|
Lee, SW; Lee, TY; Peng, YC; Yang, SS; Yeh, HZ; Chang, CS |
| 中山醫學大學 |
2020 |
Atorvastatin-induced senescence of hepatocellular carcinoma is mediated by downregulation of hTERT through the suppression of the IL-6/STAT3 pathway
|
Wang, ST; Huang, SW; Liu, KT; Lee, TY; Shieh, JJ; Wu, CY |
Showing items 11-20 of 91 (10 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page
|
